vs
Pediatrix Medical Group, Inc.（MD）とMONRO, INC.（MNRO）の財務データ比較。上の社名をクリックして会社を切り替えられます
Pediatrix Medical Group, Inc.の直近四半期売上が大きい（$493.8M vs $293.4M、MONRO, INC.の約1.7倍）。Pediatrix Medical Group, Inc.の純利益率が高く（6.8% vs 3.8%、差は3.0%）。Pediatrix Medical Group, Inc.の前年同期比売上増加率が高い（-1.7% vs -4.0%）。過去8四半期でPediatrix Medical Group, Inc.の売上複合成長率が高い（-0.1% vs -2.7%）
Pediatrix Medical Group, Inc.は米国を代表する専門医療サービスプロバイダーで、母胎医療、新生児科、小児心臓病学などの小児亜専門を中心に事業を展開し、米国全土の医療機関と提携して女性、新生児、子どもに根拠に基づく質の高い医療を提供しています。
モンロー社（Monro, Inc.）は自動車サービス企業で、創業地および本社はアメリカ合衆国ニューヨーク州ロチェスターです。2025年時点で1260店舗を展開しており、店舗数と売上高においてDriven Brandsに次ぐ北米第2位の自動車サービス企業です。
MD vs MNRO — 直接比較
損益計算書 — Q4 FY2025 vs Q3 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $493.8M | $293.4M |
| 純利益 | $33.7M | $11.1M |
| 粗利率 | — | 34.9% |
| 営業利益率 | 9.9% | 6.3% |
| 純利益率 | 6.8% | 3.8% |
| 売上前年比 | -1.7% | -4.0% |
| 純利益前年比 | 10.5% | 143.1% |
| EPS（希薄化後） | $0.40 | $0.35 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $493.8M | $293.4M | ||
| Q3 25 | $492.9M | $288.9M | ||
| Q2 25 | $468.8M | $301.0M | ||
| Q1 25 | $458.4M | $295.0M | ||
| Q4 24 | $502.4M | $305.8M | ||
| Q3 24 | $511.2M | $301.4M | ||
| Q2 24 | $504.3M | $293.2M | ||
| Q1 24 | $495.1M | $310.1M |
| Q4 25 | $33.7M | $11.1M | ||
| Q3 25 | $71.7M | $5.7M | ||
| Q2 25 | $39.3M | $-8.1M | ||
| Q1 25 | $20.7M | $-21.3M | ||
| Q4 24 | $30.5M | $4.6M | ||
| Q3 24 | $19.4M | $5.6M | ||
| Q2 24 | $-153.0M | $5.9M | ||
| Q1 24 | $4.0M | $3.7M |
| Q4 25 | — | 34.9% | ||
| Q3 25 | — | 35.7% | ||
| Q2 25 | — | 35.5% | ||
| Q1 25 | — | 33.0% | ||
| Q4 24 | — | 34.3% | ||
| Q3 24 | — | 35.3% | ||
| Q2 24 | — | 37.2% | ||
| Q1 24 | — | 35.5% |
| Q4 25 | 9.9% | 6.3% | ||
| Q3 25 | 13.8% | 4.4% | ||
| Q2 25 | 12.8% | -2.0% | ||
| Q1 25 | 7.0% | -8.1% | ||
| Q4 24 | 7.8% | 3.3% | ||
| Q3 24 | 6.6% | 4.4% | ||
| Q2 24 | -31.3% | 4.5% | ||
| Q1 24 | 3.2% | 3.3% |
| Q4 25 | 6.8% | 3.8% | ||
| Q3 25 | 14.5% | 2.0% | ||
| Q2 25 | 8.4% | -2.7% | ||
| Q1 25 | 4.5% | -7.2% | ||
| Q4 24 | 6.1% | 1.5% | ||
| Q3 24 | 3.8% | 1.9% | ||
| Q2 24 | -30.3% | 2.0% | ||
| Q1 24 | 0.8% | 1.2% |
| Q4 25 | $0.40 | $0.35 | ||
| Q3 25 | $0.84 | $0.18 | ||
| Q2 25 | $0.46 | $-0.28 | ||
| Q1 25 | $0.24 | $-0.74 | ||
| Q4 24 | $0.37 | $0.15 | ||
| Q3 24 | $0.23 | $0.18 | ||
| Q2 24 | $-1.84 | $0.19 | ||
| Q1 24 | $0.05 | $0.12 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $375.2M | $4.9M |
| 総負債低いほど良い | $570.5M | $45.0M |
| 株主資本純資産 | $865.9M | $604.9M |
| 総資産 | $2.2B | $1.6B |
| 負債/資本比率低いほどレバレッジが低い | 0.66× | 0.07× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $375.2M | $4.9M | ||
| Q3 25 | $340.1M | $10.5M | ||
| Q2 25 | $224.7M | $7.8M | ||
| Q1 25 | $99.0M | $20.8M | ||
| Q4 24 | $229.9M | $10.2M | ||
| Q3 24 | $103.8M | $20.9M | ||
| Q2 24 | $19.4M | $18.7M | ||
| Q1 24 | $8.0M | $6.6M |
| Q4 25 | $570.5M | $45.0M | ||
| Q3 25 | $577.2M | $60.0M | ||
| Q2 25 | $583.9M | $71.5M | ||
| Q1 25 | $590.5M | $61.3M | ||
| Q4 24 | $597.1M | $59.3M | ||
| Q3 24 | — | $62.0M | ||
| Q2 24 | — | $112.0M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $865.9M | $604.9M | ||
| Q3 25 | $890.7M | $601.7M | ||
| Q2 25 | $833.8M | $604.9M | ||
| Q1 25 | $789.2M | $620.8M | ||
| Q4 24 | $764.9M | $648.9M | ||
| Q3 24 | $732.5M | $651.9M | ||
| Q2 24 | $706.5M | $654.4M | ||
| Q1 24 | $856.2M | $656.8M |
| Q4 25 | $2.2B | $1.6B | ||
| Q3 25 | $2.2B | $1.6B | ||
| Q2 25 | $2.1B | $1.6B | ||
| Q1 25 | $2.0B | $1.6B | ||
| Q4 24 | $2.2B | $1.7B | ||
| Q3 24 | $2.1B | $1.7B | ||
| Q2 24 | $2.0B | $1.7B | ||
| Q1 24 | $2.2B | $1.7B |
| Q4 25 | 0.66× | 0.07× | ||
| Q3 25 | 0.65× | 0.10× | ||
| Q2 25 | 0.70× | 0.12× | ||
| Q1 25 | 0.75× | 0.10× | ||
| Q4 24 | 0.78× | 0.09× | ||
| Q3 24 | — | 0.10× | ||
| Q2 24 | — | 0.17× | ||
| Q1 24 | — | 0.16× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $114.1M | $17.8M |
| フリーキャッシュフロー営業CF - 設備投資 | — | $9.1M |
| FCFマージンFCF / 売上 | — | 3.1% |
| 設備投資強度設備投資 / 売上 | — | 3.0% |
| キャッシュ転換率営業CF / 純利益 | 3.39× | 1.60× |
| 直近12ヶ月FCF直近4四半期 | — | $49.6M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $114.1M | $17.8M | ||
| Q3 25 | $137.3M | $32.3M | ||
| Q2 25 | $137.2M | $-1.9M | ||
| Q1 25 | $-117.5M | $28.9M | ||
| Q4 24 | $133.0M | $14.8M | ||
| Q3 24 | $91.8M | $62.6M | ||
| Q2 24 | $107.0M | $25.6M | ||
| Q1 24 | $-125.2M | $-5.3M |
| Q4 25 | — | $9.1M | ||
| Q3 25 | — | $26.6M | ||
| Q2 25 | — | $-9.3M | ||
| Q1 25 | — | $23.2M | ||
| Q4 24 | — | $7.9M | ||
| Q3 24 | — | $57.6M | ||
| Q2 24 | — | $16.8M | ||
| Q1 24 | — | $-11.9M |
| Q4 25 | — | 3.1% | ||
| Q3 25 | — | 9.2% | ||
| Q2 25 | — | -3.1% | ||
| Q1 25 | — | 7.9% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | 19.1% | ||
| Q2 24 | — | 5.7% | ||
| Q1 24 | — | -3.8% |
| Q4 25 | — | 3.0% | ||
| Q3 25 | — | 2.0% | ||
| Q2 25 | — | 2.5% | ||
| Q1 25 | — | 1.9% | ||
| Q4 24 | — | 2.2% | ||
| Q3 24 | — | 1.6% | ||
| Q2 24 | — | 3.0% | ||
| Q1 24 | — | 2.1% |
| Q4 25 | 3.39× | 1.60× | ||
| Q3 25 | 1.91× | 5.71× | ||
| Q2 25 | 3.49× | — | ||
| Q1 25 | -5.66× | — | ||
| Q4 24 | 4.36× | 3.23× | ||
| Q3 24 | 4.72× | 11.08× | ||
| Q2 24 | — | 4.37× | ||
| Q1 24 | -31.03× | -1.42× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
MNRO
| Tires | $150.2M | 51% |
| Maintenance | $73.5M | 25% |
| Brakes | $35.1M | 12% |
| Steering | $24.9M | 8% |
| Batteries | $6.2M | 2% |
| Exhaust | $3.2M | 1% |
